Overview

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the clinical response rates of doripenem versus a comparator antibiotic in treatment of hospitalized patients with complicated intra-abdominal infections.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Collaborator:
Peninsula Pharmaceuticals, Inc.
Treatments:
Doripenem
Criteria
Inclusion Criteria:

- Has a requirement for surgical intervention within 24 hours of study entry

- Requirement of antibacterial therapy in addition to surgical intervention in certain
intra-abdominal infections.

Exclusion Criteria:

- Female patients who are pregnant, nursing, or if of child bearing potential not using
a medically accepted, effective method of birth control

- Any rapidly-progressing disease or immediately life-threatening illness.